Categorize your records by time of day or any other system that you'd like. It records glucose, food, medication, exercise and other types of information. It takes the place of traditional paper logbooks. Diabetes Pilot is the premier tool for managing diabetes on your PC. Anyone in search of a basic diabetes program might enjoy the ease of use this software provides. Preferences are limited and include the ability to set glucose ranges and to opt for an alert if a reading is outside your ranges. Diabetes Pilot Desktop offers a variety of reports, with a satisfying number of export formats, including PDF, XLS, DOC, and RTF. A searchable food database with more than 5,000 choices is a nice feature, especially with carbohydrate, fat, and calorie information provided. Buttons help you add new records for glucose readings, medication, food intake, and exercise, and a window pops up to capture information. Aside from colorful tabs for the four sections of the program-records, reports, food, and assistance-Diabetes Pilot Desktop is pretty drab. The primary outcome (change in HbA1c level at month 6) will be measured by a laboratory that isīy staff / FebruGet help monitoring glucose levels and more with this plain but functional diabetes-management program. Masking the arm allocation will be precluded by the behavioural nature of the intervention but blocking size will not be disclosed to protect concealment. new glucometer users) into three arms, namely (1) usual care (UC) only, (2) UC with process incentive and (3) UC with outcome incentive, in a 2:3:3 ratio. A total of 240 patients with suboptimally controlled diabetes (HbA1c 8%) from a polyclinic in Singapore are block-randomised (blocking factor: current vs. TRIAD is a randomised, controlled, open-label, single-centre superiority trial with three parallel arms. In the Trial to Incentivise Adherence for Diabetes (TRIAD) we test whether adding financial incentives to usual care can improve HbA1c levels among people with diabetes and whether the financial incentives work better when targeting processes (adherence to blood glucose testing, medication, and daily physical activity) or the primary intermediary health outcome of self-monitored blood glucose within an acceptable range. Whereas there is evidence that rewards can improve treatment adherence and sometimes health outcomes, further research is needed to determine whether rewards are more effective when targeting processes or intermediary health outcomes. One strategy to address this discontinuity is to offer patients a near-term benefit, such as a financial reward. Behavioural economic theory suggests that the lack of adherence results from the disconnect between the timing of when costs and benefits accrue. Trial to Incentivise Adherence for Diabetes (TRIAD): study protocol for a randomised controlled trial Many people with diabetes have suboptimal glycaemic control due to not being adherent to their treatment regimen. Trial To Incentivise Adherence For Diabetes (triad): Study Protocol For A Randomised Controlled Trial
0 Comments
Leave a Reply. |